董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Blaise Aguirre | 男 | Director | 59 | 2.50万美元 | 未持股 | 2023-11-17 |
| Joseph Bardswich | 男 | Director | 76 | 2.50万美元 | 未持股 | 2023-11-17 |
| Gary C. Evans | 男 | Chairman of the Board | 66 | 0.21万美元 | 未持股 | 2023-11-17 |
| Michael McManus | 男 | Director | 80 | 未披露 | 未持股 | 2023-11-17 |
| John C. Gustavsen | 男 | Chief Executive Officer and Director | 75 | 11.13万美元 | 未持股 | 2023-11-17 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Kelly J. Stopher | 男 | Chief Financial Officer | 60 | 7.20万美元 | 未持股 | 2023-11-17 |
| Mitzi Hart | 女 | Controller, Secretary and Treasurer | 54 | 未披露 | 未持股 | 2023-11-17 |
| John C. Gustavsen | 男 | Chief Executive Officer and Director | 75 | 11.13万美元 | 未持股 | 2023-11-17 |
董事简历
中英对照 | 中文 | 英文- Blaise Aguirre
-
Blaise Aguirre MD于2019年8月14日加入美国Antimony Corp.董事会，取代因医疗原因退休的一名董事。他于1989年获得University of the Witwatersrand的医学博士学位，并于1991年至1994年在波士顿大学医学院担任住院医师。他是哈佛医学院的精神病学助理教授，也是McLean医院east 3East的创始医疗主任。Aguirre博士能说流利的西班牙语，并在世界各地演讲。他于2011年当选为Investors Capital Holdings, Ltd的董事会成员，并一直担任董事会成员，直到该公司被出售给RCAP。他是多家私人控股公司的董事会成员。他与机构资金经理、风险资本家、天使投资人建立并保持着持久的关系，并作为小型股分析师和经纪人发展了专业知识，拥有第7轮和第63轮证券许可证。
Blaise Aguirre,joined the Board in August 2019. He received his Medical Doctor's degree in 1989 from the University of the Witwatersrand, Johannesburg, South Africa, and performed his residency at Boston University School of Medicine from 1991 to 1994. He has served as an Assistant Professor of Psychiatry at Harvard Medical School since 2011, and he has served as the founding Medical Director of 3East at McLean Hospital since 2007. Dr. Aguirre is fluent in Spanish and lectures worldwide. He was elected to the Board at Investors Capital Holdings, Ltd in 2011 and remained on the Board until it was sold to RCAP in 2013. He sits on the boards of various privately held companies. - Blaise Aguirre MD于2019年8月14日加入美国Antimony Corp.董事会，取代因医疗原因退休的一名董事。他于1989年获得University of the Witwatersrand的医学博士学位，并于1991年至1994年在波士顿大学医学院担任住院医师。他是哈佛医学院的精神病学助理教授，也是McLean医院east 3East的创始医疗主任。Aguirre博士能说流利的西班牙语，并在世界各地演讲。他于2011年当选为Investors Capital Holdings, Ltd的董事会成员，并一直担任董事会成员，直到该公司被出售给RCAP。他是多家私人控股公司的董事会成员。他与机构资金经理、风险资本家、天使投资人建立并保持着持久的关系，并作为小型股分析师和经纪人发展了专业知识，拥有第7轮和第63轮证券许可证。
- Blaise Aguirre,joined the Board in August 2019. He received his Medical Doctor's degree in 1989 from the University of the Witwatersrand, Johannesburg, South Africa, and performed his residency at Boston University School of Medicine from 1991 to 1994. He has served as an Assistant Professor of Psychiatry at Harvard Medical School since 2011, and he has served as the founding Medical Director of 3East at McLean Hospital since 2007. Dr. Aguirre is fluent in Spanish and lectures worldwide. He was elected to the Board at Investors Capital Holdings, Ltd in 2011 and remained on the Board until it was sold to RCAP in 2013. He sits on the boards of various privately held companies.
- Joseph Bardswich
-
Joseph Bardswich在采矿、采矿工程、管理、钻井、冶金和工厂设计方面有着丰富的经验。他是一名注册的专业采矿工程师，可以担任NI43-101标准的QP合格人员，曾担任轮班领班、矿山安全工程师、矿山领班、矿山经理和采矿顾问。
Joseph Bardswich,joined the Board in February 2021. He has extensive experience in mining, mining engineering, management, drilling, metallurgy and plant design. He is a registered professional mining engineer in the State of Arizona and the Province of Ontario, and is a qualified person as described in S-K 1300. Since July 15, 2015, he has served as President of L.J. Bardswich Mine Consultant Inc., a Montana S corporation which provides consulting services to the mining industry. He also presently serves as the President of Golden Vertex Corp. the wholly owned (Arizona C Corporation) subsidiary of Elevation Gold Mining Corporation (TSXV -ELVT), from July 10, 2017. He also served as a director of Northern Vertex Mining Corporation (TSXV-NEE) from 2010 to February 2021, when Northern Vertex Mining Corporation (TSXV -NEE) acquired Eclipse Gold Mining Corporation (EGLD - TSXV). On September 24, 2021, Northern Vertex Mining Corporation (TSXV -NEE) changed its name to Elevation Gold Mining Corporation TSXV-ELVT. (OTC: NHVCD). He also presently serves as President and as a Director of Frisco Gold Corporation, an Arizona S corporation, since October 14, 2019, to the present. - Joseph Bardswich在采矿、采矿工程、管理、钻井、冶金和工厂设计方面有着丰富的经验。他是一名注册的专业采矿工程师，可以担任NI43-101标准的QP合格人员，曾担任轮班领班、矿山安全工程师、矿山领班、矿山经理和采矿顾问。
- Joseph Bardswich,joined the Board in February 2021. He has extensive experience in mining, mining engineering, management, drilling, metallurgy and plant design. He is a registered professional mining engineer in the State of Arizona and the Province of Ontario, and is a qualified person as described in S-K 1300. Since July 15, 2015, he has served as President of L.J. Bardswich Mine Consultant Inc., a Montana S corporation which provides consulting services to the mining industry. He also presently serves as the President of Golden Vertex Corp. the wholly owned (Arizona C Corporation) subsidiary of Elevation Gold Mining Corporation (TSXV -ELVT), from July 10, 2017. He also served as a director of Northern Vertex Mining Corporation (TSXV-NEE) from 2010 to February 2021, when Northern Vertex Mining Corporation (TSXV -NEE) acquired Eclipse Gold Mining Corporation (EGLD - TSXV). On September 24, 2021, Northern Vertex Mining Corporation (TSXV -NEE) changed its name to Elevation Gold Mining Corporation TSXV-ELVT. (OTC: NHVCD). He also presently serves as President and as a Director of Frisco Gold Corporation, an Arizona S corporation, since October 14, 2019, to the present.
- Gary C. Evans
-
Gary C. Evans于2022年11月加入董事会。他在公共和私营金融业务部门拥有丰富的经验，并在数十亿美元公司的初创企业中拥有创业专长。此外，Gary C. Evans也有与投资者关系和金融机构成功打交道的历史。这一系列的特点使埃文斯先生成为一个伟大的和非常需要的补充United States Antimony Corporation董事会。Gary C. Evans目前担任Evergreen Sustainable Enterprises，Inc.（EGSE）董事会主席兼首席执行官，该公司是一家上市的可持续能源转型和大麻公司，目前在OTCQB交易，市值约为5000万美元，自2016年以来一直担任该职位。EGSE通过在大麻行业的各种收购实现了多元化，主要是在中游行业。埃文斯曾于2009年至2016年领导Magnum Hunter Resources Corporation，这是一家在纽约证券交易所上市、市值数十亿美元的公共能源公司，专门从事主要在阿巴拉契亚盆地和鹰福特的非常规资源开发。这些公司资产现在是西南能源公司（纽约证券交易所代码：SWN）的一部分。埃文斯还是Eureka Hunter Holdings，LLC的创始人和首席执行官，该公司是一家中游天然气采集公司，在类似的七年期间，从西弗吉尼亚州和俄亥俄州新建的约200英里管道上的油井生产天然气，每天输送和管理的天然气量高达1 BCF。此外，埃文斯先生曾在纽约证券交易所上市公司Magnum Hunter能源公司（Magnum Hunter Resources Inc.，简称MHRI）创立并担任董事长兼首席执行官长达20年，然后于2005年6月以大约22亿美元的价格将MHRI出售给Cimarex能源。这些资产现在是Coterra Energy公司（纽约证券交易所代码：CTRA）的一部分。在整个职业生涯中，埃文斯在华尔街筹集了超过70亿美元的各种形式的资金。埃文斯先生曾在诺瓦瓦克斯医药公司担任董事长达24年，该公司是一家在纳斯达克上市（简称NVAX）的临床阶段疫苗生物技术公司（Covid-19 Vaccine），在疫情期间市值超过150亿美元，他曾担任该公司的董事长、首席执行官和首席董事。埃文斯先生被安永会计师事务所评为2004年西南地区能源行业年度企业家，并随后入选安永企业家世界Hall of Fame。埃文斯还在2013年被评为年度能源行业领袖，并在2013年被《财经月刊》评选为最受尊敬的首席执行官之一。2013年，埃文斯先生被德州顶级制作人评选为“大公司”类最佳CEO。此外，他还获得了《财经月刊》2013年的“年度交易撮合者奖”。埃文斯是南卫理公会大学马奎尔能源研究所的董事，现在他在大麻产业会议、无线电网络和播客上就大麻产业的时事发表演讲。
Gary C. Evans,joined the Board in November 2022. He has extensive experience in the public and private financial business sectors as well as entrepreneurial expertise in start-up enterprises to multi-billion dollar corporations. Additionally, Gary C. Evans has a history of successful dealings with investor relations and financial institutions. This set of attributes makes Mr. Evans a great and much needed addition to United States Antimony Corporation Board. Gary C. Evans presently serves as Chairman of the Board and Chief Executive Officer of Evergreen Sustainable Enterprises, Inc. ("EGSE"), a publicly held, sustainable energy transition and hemp company that currently trades on the OTCQB with an approximate $50 Million market capitalization, a position he has held since 2016. EGSE has diversified through various acquisitions in the hemp industry, predominantly within the midstream sector. Mr. Evans previously led Magnum Hunter Resources Corporation, a NYSE listed multibillion-dollar public energy company specializing in unconventional resource plays predominately in the Appalachian Basin and the Eagle Ford, from 2009 to 2016. These corporate assets are now part of Southwestern Energy Co. (NYSE: SWN). Mr. Evans was also founder and CEO of Eureka Hunter Holdings, LLC, a mid-stream gas gathering company transporting and managing up to 1 BCF of daily natural gas volumes from wells producing in West Virginia and Ohio on approximately 200 miles of newly constructed pipeline during the similar seven-year period. Additionally, Mr. Evans previously founded and served as the Chairman and Chief Executive Officer of Magnum Hunter Resources Inc. (MHRI), a NYSE listed company, for twenty years before selling MHRI to Cimarex Energy for approximately $2.2 billion in June 2005. These assets are now part of Coterra Energy, Inc. (NYSE: CTRA). Throughout his career, Mr. Evans has raised various forms of capital on Wall Street that have exceeded $7 Billion. Mr. Evans has previously served for 24 years as a Director of Novavax Inc., a NASDAQ listed ("NVAX") clinical-stage vaccine biotechnology company (Covid-19 Vaccine) which reached a market capitalization in excess of $15 Billion during the pandemic, where he previously also served as Chairman, CEO and Lead Director. Mr. Evans was recognized by Ernst and Young as the Southwest Area 2004 Entrepreneur of the Year for the Energy Sector and was subsequently inducted into the World Hall of Fame for Ernst & Young Entrepreneurs. Mr. Evans was also recognized as the Energy Industry Leader of the year in 2013 and chosen by Finance Monthly in 2013 as one of the most respected CEO's. Mr. Evans was chosen as the Best CEO in the "Large Company" category by Texas Top Producers in 2013. He additionally won the Deal Maker of the Year Award in 2013 by Finance Monthly. Mr. Evans serves on the Board of the Maguire Energy Institute at Southern Methodist University and now speaks on the current affairs of the hemp industry at hemp industry conferences, on radio networks, and podcasts. - Gary C. Evans于2022年11月加入董事会。他在公共和私营金融业务部门拥有丰富的经验，并在数十亿美元公司的初创企业中拥有创业专长。此外，Gary C. Evans也有与投资者关系和金融机构成功打交道的历史。这一系列的特点使埃文斯先生成为一个伟大的和非常需要的补充United States Antimony Corporation董事会。Gary C. Evans目前担任Evergreen Sustainable Enterprises，Inc.（EGSE）董事会主席兼首席执行官，该公司是一家上市的可持续能源转型和大麻公司，目前在OTCQB交易，市值约为5000万美元，自2016年以来一直担任该职位。EGSE通过在大麻行业的各种收购实现了多元化，主要是在中游行业。埃文斯曾于2009年至2016年领导Magnum Hunter Resources Corporation，这是一家在纽约证券交易所上市、市值数十亿美元的公共能源公司，专门从事主要在阿巴拉契亚盆地和鹰福特的非常规资源开发。这些公司资产现在是西南能源公司（纽约证券交易所代码：SWN）的一部分。埃文斯还是Eureka Hunter Holdings，LLC的创始人和首席执行官，该公司是一家中游天然气采集公司，在类似的七年期间，从西弗吉尼亚州和俄亥俄州新建的约200英里管道上的油井生产天然气，每天输送和管理的天然气量高达1 BCF。此外，埃文斯先生曾在纽约证券交易所上市公司Magnum Hunter能源公司（Magnum Hunter Resources Inc.，简称MHRI）创立并担任董事长兼首席执行官长达20年，然后于2005年6月以大约22亿美元的价格将MHRI出售给Cimarex能源。这些资产现在是Coterra Energy公司（纽约证券交易所代码：CTRA）的一部分。在整个职业生涯中，埃文斯在华尔街筹集了超过70亿美元的各种形式的资金。埃文斯先生曾在诺瓦瓦克斯医药公司担任董事长达24年，该公司是一家在纳斯达克上市（简称NVAX）的临床阶段疫苗生物技术公司（Covid-19 Vaccine），在疫情期间市值超过150亿美元，他曾担任该公司的董事长、首席执行官和首席董事。埃文斯先生被安永会计师事务所评为2004年西南地区能源行业年度企业家，并随后入选安永企业家世界Hall of Fame。埃文斯还在2013年被评为年度能源行业领袖，并在2013年被《财经月刊》评选为最受尊敬的首席执行官之一。2013年，埃文斯先生被德州顶级制作人评选为“大公司”类最佳CEO。此外，他还获得了《财经月刊》2013年的“年度交易撮合者奖”。埃文斯是南卫理公会大学马奎尔能源研究所的董事，现在他在大麻产业会议、无线电网络和播客上就大麻产业的时事发表演讲。
- Gary C. Evans,joined the Board in November 2022. He has extensive experience in the public and private financial business sectors as well as entrepreneurial expertise in start-up enterprises to multi-billion dollar corporations. Additionally, Gary C. Evans has a history of successful dealings with investor relations and financial institutions. This set of attributes makes Mr. Evans a great and much needed addition to United States Antimony Corporation Board. Gary C. Evans presently serves as Chairman of the Board and Chief Executive Officer of Evergreen Sustainable Enterprises, Inc. ("EGSE"), a publicly held, sustainable energy transition and hemp company that currently trades on the OTCQB with an approximate $50 Million market capitalization, a position he has held since 2016. EGSE has diversified through various acquisitions in the hemp industry, predominantly within the midstream sector. Mr. Evans previously led Magnum Hunter Resources Corporation, a NYSE listed multibillion-dollar public energy company specializing in unconventional resource plays predominately in the Appalachian Basin and the Eagle Ford, from 2009 to 2016. These corporate assets are now part of Southwestern Energy Co. (NYSE: SWN). Mr. Evans was also founder and CEO of Eureka Hunter Holdings, LLC, a mid-stream gas gathering company transporting and managing up to 1 BCF of daily natural gas volumes from wells producing in West Virginia and Ohio on approximately 200 miles of newly constructed pipeline during the similar seven-year period. Additionally, Mr. Evans previously founded and served as the Chairman and Chief Executive Officer of Magnum Hunter Resources Inc. (MHRI), a NYSE listed company, for twenty years before selling MHRI to Cimarex Energy for approximately $2.2 billion in June 2005. These assets are now part of Coterra Energy, Inc. (NYSE: CTRA). Throughout his career, Mr. Evans has raised various forms of capital on Wall Street that have exceeded $7 Billion. Mr. Evans has previously served for 24 years as a Director of Novavax Inc., a NASDAQ listed ("NVAX") clinical-stage vaccine biotechnology company (Covid-19 Vaccine) which reached a market capitalization in excess of $15 Billion during the pandemic, where he previously also served as Chairman, CEO and Lead Director. Mr. Evans was recognized by Ernst and Young as the Southwest Area 2004 Entrepreneur of the Year for the Energy Sector and was subsequently inducted into the World Hall of Fame for Ernst & Young Entrepreneurs. Mr. Evans was also recognized as the Energy Industry Leader of the year in 2013 and chosen by Finance Monthly in 2013 as one of the most respected CEO's. Mr. Evans was chosen as the Best CEO in the "Large Company" category by Texas Top Producers in 2013. He additionally won the Deal Maker of the Year Award in 2013 by Finance Monthly. Mr. Evans serves on the Board of the Maguire Energy Institute at Southern Methodist University and now speaks on the current affairs of the hemp industry at hemp industry conferences, on radio networks, and podcasts.
- Michael McManus
-
Michael McManus，是公认的领导者和企业建设者，曾成功担任上市公司CEO、资深政府经验、律师、新产品开发负责人，并曾担任多家公司的董事会成员。McManus先生曾担任诺瓦瓦克斯医药的董事会成员，该公司是一家生物技术公司，致力于通过发现、开发和向世界各地的患者提供创新疫苗，帮助解决全球范围内的严重传染病问题。McManus先生此前自1998年起担任Misonix, Inc.的总裁、首席执行官兼董事，该公司是一家医疗、科学和工业领域的超声波和空气污染系统供应商。在此之前，他曾于1991年至1998年担任New York Bancorp Inc.的总裁兼首席执行官。从1990年到1991年11月，McManus先生在Jamcor Pharmaceuticals Inc.担任总裁兼首席执行官。此前，McManus先生在1982至1985年期间担任美国总统助理，曾在辉瑞公司和露华浓集团任职。McManus先生获得圣母大学经济学学士学位和乔治城大学法律中心京东学位。1968年至1970年，他在美国陆军步兵部队服役。他也是埃利斯岛荣誉勋章的获得者。
Michael McManus,is a recognized leader and builder of enterprises with successes as a public company CEO, senior government experience, a lawyer, new product development leader, and has served as a board member of several companies. Mr. McManus served as a board member of Novavax, a biotechnology company committed to help address serious infectious diseases globally through the discovery, development, and delivery of innovative vaccines to patients around the world. Mr. McManus has previously served as president, chief executive officer, and director at Misonix, Inc., a medical, scientific, and industrial provider of ultrasonic and air pollution systems, since 1998. Prior to that tenure, he was president and chief executive officer at New York Bancorp Inc. from 1991 to 1998. From 1990 through November 1991, Mr. McManus was president and chief executive officer at Jamcor Pharmaceuticals Inc. Previously, Mr. McManus served as an assistant to the President of the United States from 1982 to 1985 and held positions with Pfizer Inc. and Revlon Group. Mr. McManus received a BA in economics from the University of Notre Dame and a JD from the Georgetown University Law Center. He served in the US Army Infantry from 1968 through 1970. He is also a recipient of the Ellis Island Medal of Honor. - Michael McManus，是公认的领导者和企业建设者，曾成功担任上市公司CEO、资深政府经验、律师、新产品开发负责人，并曾担任多家公司的董事会成员。McManus先生曾担任诺瓦瓦克斯医药的董事会成员，该公司是一家生物技术公司，致力于通过发现、开发和向世界各地的患者提供创新疫苗，帮助解决全球范围内的严重传染病问题。McManus先生此前自1998年起担任Misonix, Inc.的总裁、首席执行官兼董事，该公司是一家医疗、科学和工业领域的超声波和空气污染系统供应商。在此之前，他曾于1991年至1998年担任New York Bancorp Inc.的总裁兼首席执行官。从1990年到1991年11月，McManus先生在Jamcor Pharmaceuticals Inc.担任总裁兼首席执行官。此前，McManus先生在1982至1985年期间担任美国总统助理，曾在辉瑞公司和露华浓集团任职。McManus先生获得圣母大学经济学学士学位和乔治城大学法律中心京东学位。1968年至1970年，他在美国陆军步兵部队服役。他也是埃利斯岛荣誉勋章的获得者。
- Michael McManus,is a recognized leader and builder of enterprises with successes as a public company CEO, senior government experience, a lawyer, new product development leader, and has served as a board member of several companies. Mr. McManus served as a board member of Novavax, a biotechnology company committed to help address serious infectious diseases globally through the discovery, development, and delivery of innovative vaccines to patients around the world. Mr. McManus has previously served as president, chief executive officer, and director at Misonix, Inc., a medical, scientific, and industrial provider of ultrasonic and air pollution systems, since 1998. Prior to that tenure, he was president and chief executive officer at New York Bancorp Inc. from 1991 to 1998. From 1990 through November 1991, Mr. McManus was president and chief executive officer at Jamcor Pharmaceuticals Inc. Previously, Mr. McManus served as an assistant to the President of the United States from 1982 to 1985 and held positions with Pfizer Inc. and Revlon Group. Mr. McManus received a BA in economics from the University of Notre Dame and a JD from the Georgetown University Law Center. He served in the US Army Infantry from 1968 through 1970. He is also a recipient of the Ellis Island Medal of Honor.
- John C. Gustavsen
-
John C. Gustavsen，他于1970年毕业于Rutgers University，获得化学学士学位，也曾任职Harshaw Chemical （被Amspec Chemical Corporation收购，三氧化锑的大型生产商）。他曾接受工程课程（从1976年到1980年），并于1983年成为公司的总裁兼财务主管。他于1990年被提拔为首席执行官。他于2011年11月开始任职United States Antimony Corporation。
John C. Gustavsen,graduated from Rutgers University in 1970 with a BS in chemistry and started work for Harshaw Chemical (purchased by Amspec Chemical Corporation), a major producer of antimony trioxide. Mr. Gustavsen took engineering courses from 1976 through 1980, and became president and treasurer of the Company in 1983. He was promoted to CEO in 1990. Mr. Gustavsen designed a new type of production furnace for antimony trioxide that eventually produced 20 million pounds of antimony trioxide per year. Mr. Gustavsen is conversant in Spanish, Chinese, and other languages, and travelled to many countries as part of his duties as president of Amspec Chemical Corporation. Mr. Gustavsen joined the Company in November 2011 as one of its Vice Presidents, and in June 2020 was promoted to Chief Executive Officer. He joined the Board in August 2022. - John C. Gustavsen，他于1970年毕业于Rutgers University，获得化学学士学位，也曾任职Harshaw Chemical （被Amspec Chemical Corporation收购，三氧化锑的大型生产商）。他曾接受工程课程（从1976年到1980年），并于1983年成为公司的总裁兼财务主管。他于1990年被提拔为首席执行官。他于2011年11月开始任职United States Antimony Corporation。
- John C. Gustavsen,graduated from Rutgers University in 1970 with a BS in chemistry and started work for Harshaw Chemical (purchased by Amspec Chemical Corporation), a major producer of antimony trioxide. Mr. Gustavsen took engineering courses from 1976 through 1980, and became president and treasurer of the Company in 1983. He was promoted to CEO in 1990. Mr. Gustavsen designed a new type of production furnace for antimony trioxide that eventually produced 20 million pounds of antimony trioxide per year. Mr. Gustavsen is conversant in Spanish, Chinese, and other languages, and travelled to many countries as part of his duties as president of Amspec Chemical Corporation. Mr. Gustavsen joined the Company in November 2011 as one of its Vice Presidents, and in June 2020 was promoted to Chief Executive Officer. He joined the Board in August 2022.
高管简历
中英对照 | 中文 | 英文- Kelly J. Stopher
Kelly J. Stopher，自2021年12月起担任公司首席财务官。Stopher先生自2018年1月起担任Palouse Advisory Partners，LLC的管理合伙人，为客户提供首席财务官（“CFO”）服务。Stopher先生为许多小型公司制定了实施财务管理系统、内部控制政策和程序、财务报告和建模的战略。Stopher先生于2010年10月20日被任命为Star Gold Corp.的首席财务官，Star Gold Corp.是一家总部位于美国的公司，通过OTC Markets上市，目前仍担任该职位。斯托弗还自2021年11月起担任Epilog Imaging Systems，Inc.的首席财务官。斯托弗曾于2020年2月至2021年11月担任Zenlabs Holdings，Inc.的首席财务官。斯托弗先生拥有华盛顿州立大学会计学学士学位。他的公共会计职业生涯始于Langlow Tolles & Company，PS，这是一家位于华盛顿州塔科马的地区性注册会计师事务所，曾在多个会计和财务职位担任领导职务，包括初创公司、重组公司和成熟公司。Stopher先生还是一名注册金融建模估值分析师。
Kelly J. Stopher,has served as the Company's Chief Financial Officer since December 2021. Mr. Stopher has served as the Managing Partner of Palouse Advisory Partners, LLC since January 2018, providing Chief Financial Officer ("CFO") services to clients. Mr. Stopher has developed strategies to implement financial management systems, internal control policies and procedures, financial reporting and modeling for numerous small-cap companies. Mr. Stopher was appointed Chief Financial Officer of Star Gold Corp., a US-based company quoted via the OTC Markets, on October 20, 2010, and still holds such position. Mr. Stopher has also served as CFO for Epilog Imaging Systems, Inc. since November 2021. Mr. Stopher was previously the CFO of Zenlabs Holdings, Inc. from February 2020 to November 2021. Mr. Stopher holds a Bachelor's degree from Washington State University in Business Administration – Accounting. He started his career in public accounting with Langlow Tolles & Company, PS, a regional CPA firm based in Tacoma, WA and has worked in various accounting and finance positions of leadership including startups, reorganizations and mature companies. Mr. Stopher is also a Certified Financial Modeling Valuation Analyst.- Kelly J. Stopher，自2021年12月起担任公司首席财务官。Stopher先生自2018年1月起担任Palouse Advisory Partners，LLC的管理合伙人，为客户提供首席财务官（“CFO”）服务。Stopher先生为许多小型公司制定了实施财务管理系统、内部控制政策和程序、财务报告和建模的战略。Stopher先生于2010年10月20日被任命为Star Gold Corp.的首席财务官，Star Gold Corp.是一家总部位于美国的公司，通过OTC Markets上市，目前仍担任该职位。斯托弗还自2021年11月起担任Epilog Imaging Systems，Inc.的首席财务官。斯托弗曾于2020年2月至2021年11月担任Zenlabs Holdings，Inc.的首席财务官。斯托弗先生拥有华盛顿州立大学会计学学士学位。他的公共会计职业生涯始于Langlow Tolles & Company，PS，这是一家位于华盛顿州塔科马的地区性注册会计师事务所，曾在多个会计和财务职位担任领导职务，包括初创公司、重组公司和成熟公司。Stopher先生还是一名注册金融建模估值分析师。
- Kelly J. Stopher,has served as the Company's Chief Financial Officer since December 2021. Mr. Stopher has served as the Managing Partner of Palouse Advisory Partners, LLC since January 2018, providing Chief Financial Officer ("CFO") services to clients. Mr. Stopher has developed strategies to implement financial management systems, internal control policies and procedures, financial reporting and modeling for numerous small-cap companies. Mr. Stopher was appointed Chief Financial Officer of Star Gold Corp., a US-based company quoted via the OTC Markets, on October 20, 2010, and still holds such position. Mr. Stopher has also served as CFO for Epilog Imaging Systems, Inc. since November 2021. Mr. Stopher was previously the CFO of Zenlabs Holdings, Inc. from February 2020 to November 2021. Mr. Stopher holds a Bachelor's degree from Washington State University in Business Administration – Accounting. He started his career in public accounting with Langlow Tolles & Company, PS, a regional CPA firm based in Tacoma, WA and has worked in various accounting and finance positions of leadership including startups, reorganizations and mature companies. Mr. Stopher is also a Certified Financial Modeling Valuation Analyst.
- Mitzi Hart
Mitzi Hart，自2023年2月起担任United States Antimony Corporation财务总监、秘书和财务主管。她曾担任露天矿Kerr Inc.的办公室经理，担任会计、发薪文员、MSHA联系人、DOT联系人和财务总监。她还与地方和州政府办公室合作提交投标和账单。她有采矿作业的经验，包括筛选、破碎、卡车运输等。克尔工厂还包括一家沥青厂、一家伐木公司，她负责调度、调度、计费以及供应和交付的物流。她最初于2021年9月接替了美国锑汤普森瀑布厂经理玛丽莲·辛克。
Mitzi Hart,has served as United States Antimony Corporation Controller, Secretary and Treasurer since February 2023. She previously served as office manager for Kerr Inc., an open pit mine in the capacity of accountant, payroll clerk, MSHA contact, DOT contact and Controller. She also worked with local and state government offices on submitting bids and billing. She has experience with mining operations, including screening, crushing, trucking, etc. The Kerr plant also included an asphalt plant, a logging company, and she was in control of dispatch, scheduling, billing and logistics of supply and delivery. She originally replaced the U.S. Antimony Thompson Falls Plant Manager, Marilyn Sink, in September 2021.- Mitzi Hart，自2023年2月起担任United States Antimony Corporation财务总监、秘书和财务主管。她曾担任露天矿Kerr Inc.的办公室经理，担任会计、发薪文员、MSHA联系人、DOT联系人和财务总监。她还与地方和州政府办公室合作提交投标和账单。她有采矿作业的经验，包括筛选、破碎、卡车运输等。克尔工厂还包括一家沥青厂、一家伐木公司，她负责调度、调度、计费以及供应和交付的物流。她最初于2021年9月接替了美国锑汤普森瀑布厂经理玛丽莲·辛克。
- Mitzi Hart,has served as United States Antimony Corporation Controller, Secretary and Treasurer since February 2023. She previously served as office manager for Kerr Inc., an open pit mine in the capacity of accountant, payroll clerk, MSHA contact, DOT contact and Controller. She also worked with local and state government offices on submitting bids and billing. She has experience with mining operations, including screening, crushing, trucking, etc. The Kerr plant also included an asphalt plant, a logging company, and she was in control of dispatch, scheduling, billing and logistics of supply and delivery. She originally replaced the U.S. Antimony Thompson Falls Plant Manager, Marilyn Sink, in September 2021.
- John C. Gustavsen
John C. Gustavsen，他于1970年毕业于Rutgers University，获得化学学士学位，也曾任职Harshaw Chemical （被Amspec Chemical Corporation收购，三氧化锑的大型生产商）。他曾接受工程课程（从1976年到1980年），并于1983年成为公司的总裁兼财务主管。他于1990年被提拔为首席执行官。他于2011年11月开始任职United States Antimony Corporation。
John C. Gustavsen,graduated from Rutgers University in 1970 with a BS in chemistry and started work for Harshaw Chemical (purchased by Amspec Chemical Corporation), a major producer of antimony trioxide. Mr. Gustavsen took engineering courses from 1976 through 1980, and became president and treasurer of the Company in 1983. He was promoted to CEO in 1990. Mr. Gustavsen designed a new type of production furnace for antimony trioxide that eventually produced 20 million pounds of antimony trioxide per year. Mr. Gustavsen is conversant in Spanish, Chinese, and other languages, and travelled to many countries as part of his duties as president of Amspec Chemical Corporation. Mr. Gustavsen joined the Company in November 2011 as one of its Vice Presidents, and in June 2020 was promoted to Chief Executive Officer. He joined the Board in August 2022.- John C. Gustavsen，他于1970年毕业于Rutgers University，获得化学学士学位，也曾任职Harshaw Chemical （被Amspec Chemical Corporation收购，三氧化锑的大型生产商）。他曾接受工程课程（从1976年到1980年），并于1983年成为公司的总裁兼财务主管。他于1990年被提拔为首席执行官。他于2011年11月开始任职United States Antimony Corporation。
- John C. Gustavsen,graduated from Rutgers University in 1970 with a BS in chemistry and started work for Harshaw Chemical (purchased by Amspec Chemical Corporation), a major producer of antimony trioxide. Mr. Gustavsen took engineering courses from 1976 through 1980, and became president and treasurer of the Company in 1983. He was promoted to CEO in 1990. Mr. Gustavsen designed a new type of production furnace for antimony trioxide that eventually produced 20 million pounds of antimony trioxide per year. Mr. Gustavsen is conversant in Spanish, Chinese, and other languages, and travelled to many countries as part of his duties as president of Amspec Chemical Corporation. Mr. Gustavsen joined the Company in November 2011 as one of its Vice Presidents, and in June 2020 was promoted to Chief Executive Officer. He joined the Board in August 2022.